University of Zurich COVID-19 Vax Adverse Effect Study: 0.7% Rate of Hospitalization

A team at the University of Zurich, Epidemiology, Biostatistics and Prevention Institute (EBPI) led a population-based cohort study involving 575 individuals who received a SARS-CoV-2 vaccine, and as part of the study, were monitored and followed up over 12 weeks, with participants sharing commonly reported adverse effects, mostly local pain, fatigue, headache and fever. Not surprisingly, a majority of adverse effects were mild to moderate and resolved within three days. The findings here are comparable to other reported prevalence and severity of adverse effects in randomized controlled trials. Hospitalizations out of the cohort totaled 0.7%.

Context